DekaBank Deutsche Girozentrale’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $530K | Hold |
7,550
| – | – | ﹤0.01% | 974 |
|
|
2025
Q1 | $489K | Hold |
7,550
| – | – | ﹤0.01% | 979 |
|
|
2024
Q4 | $463K | Hold |
7,550
| – | – | ﹤0.01% | 1019 |
|
|
2024
Q3 | $488K | Hold |
7,550
| – | – | ﹤0.01% | 1019 |
|
|
2024
Q2 | $488K | Hold |
7,550
| – | – | ﹤0.01% | 1011 |
|
|
2024
Q1 | $488K | Hold |
7,550
| – | – | ﹤0.01% | 1006 |
|
|
2023
Q4 | $310K | Hold |
7,550
| – | – | ﹤0.01% | 1127 |
|
|
2023
Q3 | $246K | Hold |
7,550
| – | – | ﹤0.01% | 1155 |
|
|
2023
Q2 | $301K | Hold |
7,550
| – | – | ﹤0.01% | 1111 |
|
|
2023
Q1 | $318K | Hold |
7,550
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q4 | $362K | Hold |
7,550
| – | – | ﹤0.01% | 1113 |
|
|
2022
Q3 | $277K | Hold |
7,550
| – | – | ﹤0.01% | 1169 |
|
|
2022
Q2 | $205K | Hold |
7,550
| – | – | ﹤0.01% | 1181 |
|
|
2022
Q1 | $405K | Buy |
7,550
+700
| +10% | +$37.6K | ﹤0.01% | 1097 |
|
|
2021
Q4 | $382K | Buy |
6,850
+200
| +3% | +$11.2K | ﹤0.01% | 1158 |
|
|
2021
Q3 | $273K | Hold |
6,650
| – | – | ﹤0.01% | 1152 |
|
|
2021
Q2 | $282K | Hold |
6,650
| – | – | ﹤0.01% | 1156 |
|
|
2021
Q1 | $383K | Hold |
6,650
| – | – | ﹤0.01% | 1071 |
|
|
2020
Q4 | $496K | Buy |
+6,650
| New | +$496K | ﹤0.01% | 1021 |
|